DBDaniela De Benedictis

Daniela De Benedictis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniela De Benedictis has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hydroxytyrosol protects against paclitaxel-induced toxicity in a cellular model of chemotherapy-induced peripheral neuropathy (CIPN) by modulating mitochondrial function and cAMP/PKA signaling

    by Daniela De Benedictis, Aasia Bibi, Maria Laura Matrella, Bruna Amenta, Rossana Franzin, Paola Pontrelli, Vittorio Calabrese, Uwe Wenzel, Tiziana Cocco, Domenico De Rasmo, et al.

    Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect of some anticancer treatments, often persisting beyond therapy and severely affecting patient quality of life. Mitochondrial dysfunction has emerged as a key contributor to CIPN pathogenesis, yet the underlying molecular mechanisms remain incompletely understood. Paclitaxel (PTX) is a widely used chemotherapeutic agent whose neurotoxicity is linked to oxidative stress, mitochondrial dysfunction, and apoptosis. Here, we investigated whether the polyphenols hydroxytyrosol (HT) and resveratrol (RSV) mitigate PTX-induced damage in SH-SY5Y neuroblastoma cells. PTX induced robust apoptotic responses, including increased DAPI staining, reduced cell viability and increased late apoptotic cells. HT significantly attenuated these effects, whereas RSV did not provide detectable cytoprotection. Both compounds counteracted the PTX-dependent increase of ROS, but only HT preserved mitochondrial morphology, preventing the hyperfused phenotype and normalizing mitochondrial form factor and branch length by modulating DRP1 protein level and its phosphorylation at serine 637. Bioenergetic analysis showed that PTX impaired oxidative phosphorylation and glycolysis. HT partially restored mitochondrial respiration, improving coupled and maximal respiratory capacities. Mechanistically, PTX reduced cAMP levels and CREB phosphorylation. Although HT did not restore total cAMP, it rescued CREB phosphorylation. The protective effect of HT was abolished by the PKA inhibitor H89 and mimicked by 8-Br-cAMP indicating a PKA-dependent mechanism. Overall, these findings indicate HT as a protective modulator of mitochondrial homeostasis against PTX-induced neurotoxicity, acting through preservation of mitochondrial dynamics, and reactivation of cAMP/PKA signaling.

  • Open Access

    Boron-Doped Carbon Dots for Organelle Labeling and Mitochondrial Bioimaging

    by Aasia Bibi, Daniela De Benedictis, Giuseppe Capitanio, Alessandra Gabriele, Alessandro Buccolieri, Mariapompea Cutroneo, Lorenzo Torrisi, Daniela E. Manno, Antonio Serra, Domenico De Rasmo, et al.

    Background: Carbon dots (CDs) are promising fluorescent nanomaterials with great application potential in bioimaging and organelle-targeted diagnostics. This study compares nitrogen-doped (N-CDs) and boron–nitrogen co-doped CDs (BN-CDs) in normal NIH3T3 fibroblasts and KRAS-transformed cells. Methods: CDs were synthesized via a microwave-assisted method. Their fluorescence, cytocompatibility, and intracellular localization were evaluated using confocal microscopy, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, and organelle colocalization. Cellular metabolism was assessed by Seahorse analysis. Oxidative stress and cAMP levels were pharmacologically modulated. Results: BN-CDs exhibited stronger intracellular fluorescence than N-CDs, indicating enhanced uptake and imaging performance, with no cytotoxicity up to 100 µg/mL. They localized to multiple organelles, particularly mitochondria. However, fluorescence was significantly reduced in KRAS-transformed cells despite similar mitochondrial mass. BN-CDs did not affect mitochondrial respiration or glycolytic activity. Induced oxidative stress or elevated cAMP in normal cells reduced BN-CD fluorescence. Conclusions: Boron doping improves N-CD imaging properties without affecting cell viability or metabolism. Reduced fluorescence in KRAS cells is associated with altered intracellular conditions, suggesting that BN-CDs could be used to discriminate between normal and cancer cells.

  • Open Access

    Carbon Dots and Mitochondria—Advances in Targeting, Imaging, and Therapeutics

    by Aasia Bibi, Daniela De Benedictis, Giuseppe Capitanio, Alessandra Gabriele, Amer Ahmed, Mariapompea Cutroneo, Lorenzo Torrisi, Daniela Manno, Antonio Serra, Domenico De Rasmo, et al.

    Carbon dots (CDs), a class of fluorescent nanomaterials, have emerged as powerful tools for biological applications, particularly in the targeting, imaging, and therapeutic modulation of mitochondria. Due to their small size, simplicity of synthesis, biocompatibility, and tunable optical properties, CDs can be engineered to selectively accumulate in mitochondria, enabling real-time imaging of mitochondrial function and dynamics in live cells. Moreover, their ability to carry therapeutic agents, such as antioxidants, drugs, and gene delivery vectors, offers potential in treating mitochondrial dysfunction, which is central to various diseases, including neurodegenerative disorders, cancer, and metabolic diseases. Recent advancements in surface functionalization have enhanced mitochondrial targeting and specificity, while ongoing research aims to optimize the safety, efficiency, and clinical translation of CDs for therapeutic applications. This review highlights the latest developments in the use of carbon dots for mitochondrial imaging, therapeutic delivery, and disease intervention, offering promising avenues for future research and clinical applications.


  • Open Access

    Cellular cAMP Content and Mitochondrial Profile Define Different Subtypes of Ovarian Cancer Cells

    by Daniela De Benedictis, Aasia Bibi, Luigi Leonardo Palese, Antonella Cormio, Clara Musicco, Vera Loizzi, Gennaro Cormio, Ali Abdelhameed, Domenico De Rasmo, Anna Signorile

    Ovarian cancer (OC) is an aggressive and lethal gynecologic cancer due to its asymptomatic nature resulting in a late diagnosis. OC encompasses distinct histological subtypes, with serous OC representing the most common and aggressive form. However, within the same histological OC subtype, additional heterogeneity has been found in terms of genetic mutations and metabolic profiles probably contributing to treatment response. In cancer, metabolic reprogramming strongly involves mitochondria. Mitochondrial function can be regulated by the cAMP pathway, and its deregulation has been reported in various cancers including OC. Here we analyzed two serous OC cell lines, OC316 and OV56, and eleven human OC tissues. OC316 cell lines showed elevated cAMP level with respect to OV56. The high cAMP levels were associated with activation of thecAMP/PKA/CREB/PGC-1α axis resulting in increased mitochondrial biogenesis, respiratory chain activity, modulation of mitochondrial dynamics and apoptosis resistance. Accordingly, principal component analysis (PCA) of the twenty-three biochemical parameters, in eleven human OC tissues, classified OC into two groups showing different cAMP levels associated with distinct mitochondrial profiles. This analysis highlights a cAMP-dependent stratification revealing two mitochondrial subpopulations within serous OC. These findings indicate that the molecular heterogeneity of OC poses a challenge for understanding disease mechanisms and developing effective targeted therapies.